Skip Navigation

European Heart Journal 2001 22(13):1074-1081; doi:10.1053/euhj.2001.2584
Copyright © 2001 by the European Society of Cardiology.
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (32)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Hauer, R.N.W.
Right arrow Articles by Vardas, P.E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hauer, R.N.W.
Right arrow Articles by Vardas, P.E.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Working Group Reports

Indications for implantable cardioverter defibrillator (ICD) therapy. Study Group on Guidelines on ICDs of the Working Group on Arrhythmias and the Working Group on Cardiac Pacing of the European Society of Cardiology

R.N.W. Hauer (chair), Chairf1, E. Aliot, M. Block, A. Capucci, B. Lüderitz, M. Santini and P.E. Vardas

Received December 21, 2000; accepted January 21, 2001

f1 Correspondence: R. N. W. Hauer, MD, Heart Lung Center Utrecht, University Medical Center, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.

References

  1. Mirowski M, Reid PR, Mower MM. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. N Engl J Med. 1980;303:322–324[Web of Science][Medline]
  2. Wever EFD, Hauer RNW, van Capelle FL. Randomized study of implantable defibrillator as first-choice therapy versus conventional strategy in postinfarct sudden death survivors. Circulation. 1995;91:2195–2203[Abstract/Free Full Text]
  3. Wever EFD, Hauer RNW, Schrijvers G. Cost-effectiveness of implantable defibrillator as first-choice therapy versus electrophysiologically guided, tiered strategy in postinfarct sudden death survivors: a randomized study. Circulation. 1996;93:489–496[Abstract/Free Full Text]
  4. Moss AJ, Hall WJ, Cannom DS. Improved survival with an implanted defibrillator in patients with prior myocardial infarction, low ejection fraction and asymptomatic non-sustained ventricular tachycardia. N Engl J Med. 1996;335:1933–1940[Abstract/Free Full Text]
  5. N Engl J Med. 1997;337:1576–1583[Abstract/Free Full Text]
  6. Bigger JT Jr. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary artery bypass graft surgery. N Engl J Med. 1997;337:1569–1575[Abstract/Free Full Text]
  7. Kuck KH, Cappato R, Siebels J, Rüppel R. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest. The Cardiac Arrest Study Hamburg (CASH). Circulation. 2000;102:748–754[Abstract/Free Full Text]
  8. Connolly SJ, Gent M, Roberts RS. A randomized trial of the implantable cardioverter defibrillator against amiodarone. Canadian Implantable Defibrillator Study (CIDS). Circulation. 2000;101:1297–1302[Abstract/Free Full Text]
  9. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med. 1999;341:1882–1890[Abstract/Free Full Text]
  10. Viskin S, Belhassen B. Idiopathic ventricular fibrillation. Am Heart J. 1990;120:661–671[CrossRef][Web of Science][Medline]
  11. Wever EFD, Hauer RNW, Oomen A, Peters RHJ, Bakker PFA, Robles de Medina EO. Unfavorable outcome in patients with primary electrical disease who survived an episode of ventricular fibrillation. Circulation. 1993;88:1021–1029[Abstract/Free Full Text]
  12. Schneider MAE, Siebels J, Rüppel R, Kuck KH. Idiopathic ventricular fibrillation: risk stratification and 24 months follow-up in 16 patients. Pacing Clin Electrophysiol. 1993;16:949
  13. Lévy S, Hauer RNW, Raviele A, Daubert JC, Campbell RWF, Breithardt G. Recommendations for qualification of centers implanting and following defibrillators. Eur Heart J. 1996;17:1796–1799[Free Full Text]
  14. Luu M, Stevenson WG, Stevenson WL, Baron K, Walden J. Diverse mechanisms of unexpected cardiac arrest in advanced heart failure. Circulation. 1989;80:1675–1680[Abstract/Free Full Text]
  15. J Am Coll Cardiol. 1998;31:1175–1209[Free Full Text]
  16. Hohnloser SH, Andresen D, Block M. Leitlinien zur Implantation von Defibrillatoren. Z Kardiol. 2000;89:126–135[CrossRef]
  17. Mirowski M, Reid PR, Winkle RA. Mortality in patients with implanted automatic defibrillators. Ann Int Med. 1983;98:585–588[Web of Science][Medline]
  18. Böcker D, Block M, Isbruch F. Do patients with an implantable defibrillator live longer? J Am Coll Cardiol. 1993;21:1638–1648[Abstract]
  19. Powel AC, Fuchs T, Finkelstein DM. Influence of implantable cardioverter defibrillators on the long-term prognosis of survivors of out of hospital cardiac arrest. Circulation. 1993;88:1083–1092[Abstract/Free Full Text]
  20. Böcker D, Haverkamp W, Block M, Borggrefe M, Breithardt G. Comparison of d,l sotalol and implantable defibrillators for treatment of sustained ventricular tachycardia or fibrillation in patients with coronary artery disease. Circulation. 1996;94:151–157[Abstract/Free Full Text]
  21. Nicklas JM, McKenna WJ, Stewart RA. Prospective, double-blind, placebo-controlled trial of low-dose amiodarone in patients with severe heart failure and asymptomatic frequent ventricular ectopy. Am Heart J. 1991;122:1016–1021[CrossRef][Web of Science][Medline]
  22. Johnson RA, Palacios I. Dilated cardiomyopathies of the adult (first of two parts). N Engl J Med. 1982;307:1051–1058[Web of Science][Medline]
  23. Knight BP, Strickberger SA, Daoud EG. Outcome of patients with non-ischemic dilated cardiomyopathy and unexplained syncope treated with an implantable cardioverter defibrillator. Circulation. 1997;96:708
  24. Milner PG, DiMarco JP, Lerman BB. Electrophysiological evaluation of sustained ventricular tachyarrhythmias in idiopathic dilated cardiomyopathy. Pacing Clin Electrophysiol. 1998;11:562–568
  25. Böcker D, Bänsch D, Heinecke A. Potential benefit from ICD therapy in patients with and without heart failure. Circulation. 1998;98:1636–1643[Abstract/Free Full Text]
  26. McKenna WJ, Franklin RC, Nihoyannopoulos P, Robinson KC, Deanfield JE. Arrhythmia and prognosis in infants, children and adolescents with hypertrophic cardiomyopathy. J Am Coll Cardiol. 1988;11:147–153[Abstract]
  27. Nicod P, Polikar R, Peterson KL. Hypertrophic cardiomyopathy and sudden death. N Engl J Med. 1988;318:1255–1257[Web of Science][Medline]
  28. Maron BJ, Shen WK, Link MS. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med. 2000;342:365–373[Abstract/Free Full Text]
  29. Hauer RNW, Wilde AAM. Mitral valve prolapse. Zipes DP, Jalife J. Cardiac electrophysiology. From cell to bedside. 1995. p. 833–837
  30. Schwartz PJ. Idiopathic long QT syndrome: progress and questions. Am Heart J. 1985;109:399–411[CrossRef][Web of Science][Medline]
  31. Priori SG, Barhanin J, Hauer RNW. Genetic and molecular basis of cardiac arrhythmias: impact on clinical management. Eur Heart J. 1999;20:174–195[Free Full Text]
  32. Moss AJ, Zareba W, Hall WJ. Effectiveness and limitations of ß-blocker therapy in congenital long-QT syndrome. Circulation. 2000;101:616–623[Abstract/Free Full Text]
  33. Bardy GH, Bigger JT Jr, Borggrefe M. Survivors of out of hospital cardiac arrest with apparently normal heart: need for definition and standardized clinical evaluation. Consensus statement of the Joint Steering Committees of UCARE and of IVF-US. Circulation. 1997;95:265–272[Abstract/Free Full Text]
  34. Brugada P, Brugada J. Right bundle branch block, persistent ST-segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome: a multicenter report. J Am Coll Cardiol. 1992;20:1391–1396[Abstract]
  35. Block M, Breithardt G. Implantable cardioverter defibrillators: clinical aspects. Zipes DP, Jalife J. Cardiac electrophysiology: from cell to bedside. Philadelpha: W.B. Saunders Company; 2000. p. 958–970
  36. Raitt MH, Dolack GL, Kudenchuk PJ. Ventricular arrhythmias detected after transvenous defibrillator implantation in patients with a clinical history of only ventricular fibrillation: implications for use of implantable defibrillator. Circulation. 1995;91:1996–2001[Abstract/Free Full Text]
  37. Zaim S, Zaim B, Rottman J. Characterization of spontaneous recurrent ventricular arrhythmias detected by electrogram-stroing defibrillators in sudden cardiac death survivors with no inducible ventricular arrhythmias at baseline electrophysiologic testing. Am Heart J. 1996;132:274–279[CrossRef][Web of Science][Medline]
  38. Mitra RL, Hsia HH, Hook BG. Efficacy of antitachycardia pacing in patients with cardiac arrest. PACE. 1995;18:2035–2040[Medline]
  39. Mont L, Valention M, Sambola A, Matas M, Aguinaga L, Brugada J. Arrhythmia recurrence in patients with a healed myocardial infarction who received an implantable defibrillator: analysis according to the clinical presentation. J Am Coll Cardiol. 1999;34:351–357[Abstract/Free Full Text]
  40. Rosenqvist M, Beyer T, Block M, de Dulk K, Minten J, Lindemans F. Adverse events with transvenous inplantable cardioverter-defibrillators: a prospective multicenter study. Circulation. 1998;98:663–670[Abstract/Free Full Text]
  41. Swerdlow CD, Chen PS, Kass RM. Discrimination of ventricular tachycardia from sinus tachycardia and atrial fibrillation in a tiered-therapy cardioverter-defibrillator. J Am Coll Cardiol. 1994;23:1342–1355[Abstract]
  42. Neuzner J, Pitschner HF, Schlepper M. Programmable VT detection enhancements in implantable cardioverter defibrillator therapy. Pacing Clin Electrophysiol. 1995;18:539–547[CrossRef][Medline]
  43. Schaumann A, von zur Muhlen F, Gonska BD, Kreuzer H. Enhanced detection criteria in implantable cardioverter-defibrillators to avoid inappropriate therapy. Am J Cardiol. 1996;78:42–50[Web of Science][Medline]
  44. Brugada J, Mont L, Figueiredo M, Valentino M, Matas M, Navarro-Lopez F. Enhanced detection criteria in implantable defibrillators. J Cardiovasc Electrophysiol. 1998;9:262–268
  45. Weber M, Böcker D, Bänsch D. Efficacy and safety of the initial use of stability and onset criteria in implantable cardioverter defibrillator. J Cardiovasc Electrophsyiol. 1999;10:145–153[Web of Science][Medline]
  46. Brachmann J, Swerdlow CD, Mitchell BD. Worldwide experience with the electrogram width feature for improved detection in an implantable pacer-cardioverter-defibrillator. J Am Coll Cardiol. 1997;29:115a
  47. Duru F, Schonbeck M, Lüscher TF, Candinas R. The potential for inappropriate ventricular tachycardia confirmation using the Intracardiac Electrogram (EGM) Width Criterion. Pacing Clin Electrophysiol. 1999;22:1039–1046[CrossRef][Medline]
  48. Herwig S, Jung W, Wolpert C. First results with a new morphology criterion for discrimination of supraventricular and ventricular tachycardias. J Am Coll Cardiol. 2000;35:127A
  49. Lavergne T, Daubert JC, Chauvin M. Preliminary clinical experience with the first dual chamber pacemaker defibrillator. Pacing Clin Electrophysiol. 1997;20:182–188[CrossRef][Medline]
  50. Kühlkamp, V, Wilkoff, BL, Brown, AB, 7271 Gem DR Worldwide Investigators, Experience with a new dual chamber implantable defibrillator
  51. Schaumann A, von zur Muhlen F, Herse B, Gonska BD, Kreuzer H. Empirical versus tested antitachycardia pacing in implantable cardioverter defibrillators: a prospective study including 200 patients. Circulation. 1998;97:67–74
  52. Viskin S. Cardiac pacing in the long QT syndrome: review of available data and practical recommendations. J Cardiovasc Electrophysiol. 2000;11:593–600[Web of Science][Medline]
  53. Wietholt, D, First results of the Prevent study. Presented at NASPE 2000, Washington, US
  54. Leclerq C, Cazeau S, le Breton H. Acute hemodynamic effects of biventricular DDD pacing in patients with end-stage heart failure. J Am Coll Cardiol. 1998;32:1825–1831[Abstract/Free Full Text]
  55. Auricchio A, Stellbrink C, Block M. Effect of pacing chamber and atrioventricular delay on acute systolic function of paced patients with congestive heart failure. Circulation. 1999;99:2993–3001[Abstract/Free Full Text]
  56. Maron BJ, Nishimura RA, McKenna WJ, Rakowski H, Josephson ME, Kieval RS. Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy. A randomized, double-blind, crossover study (M-PATHY). Circulation. 1999;99:2927–2933[Abstract/Free Full Text]
  57. Gadler F, Linde C, Daubert C. Significant improvement of quality of life following atrioventricular synchronous pacing in patients with hypertrophic obstructive cardiomyopathy. Data from 1 year of follow-up. PIC study group. Pacing in cardiomyopathy. Eur Heart J. 1999;20:1044–1050[Abstract/Free Full Text]
  58. Swerdlow CD, Schöls W, Dijkman B. Detection of atrial fibrillation and flutter by a dual-chamber implantable cardioverter-defibrillator. Circulation. 2000;101:878–885[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J Am Coll CardiolHome page
C. I. Berul, G. F. Van Hare, N. J. Kertesz, A. M. Dubin, F. Cecchin, K. K. Collins, B. C. Cannon, M. E. Alexander, J. K. Triedman, E. P. Walsh, et al.
Results of a Multicenter Retrospective Implantable Cardioverter-Defibrillator Registry of Pediatric and Congenital Heart Disease Patients
J. Am. Coll. Cardiol., April 29, 2008; 51(17): 1685 - 1691.
[Abstract] [Full Text] [PDF]

Home page
 J. Med. EthicsHome page
A. Agard, R. Lofmark, N. Edvardsson, and I. Ekman
Views of patients with heart failure about their role in the decision to start implantable cardioverter defibrillator treatment: prescription rather than participation
J. Med. Ethics, September 1, 2007; 33(9): 514 - 518.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
E. A. Stephenson and C. I. Berul
Electrophysiological Interventions for Inherited Arrhythmia Syndromes
Circulation, August 28, 2007; 116(9): 1062 - 1080.
[Full Text] [PDF]

Home page
 Eur J EchocardiogrHome page
R. Olszewski, J. Timperley, S. Cezary, M. Monaghan, P. Nihoyannopoulis, R. Senior, and H. Becher
The clinical applications of contrast echocardiography
Eur J Echocardiogr, June 1, 2007; 8(3): s13 - s23.
[Full Text] [PDF]

Home page
 Emerg. Med. J.Home page
C.-P. Liu, Y.-L. Ho, Y.-H. Lin, Y.-B. Liu, W.-T. Chang, C.-H. Huang, and W.-J. Chen
Management of patients with implantable cardioverter defibrillators at emergency departments
Emerg. Med. J., February 1, 2007; 24(2): 106 - 109.
[Abstract] [Full Text] [PDF]

Home page
 EuropaceHome page
E.G. Newall, N.A. Lever, S. Prasad, C. Hornabrook, and P.D. Larsen
Psychological implications of ICD implantation in a New Zealand population
Europace, January 1, 2007; 9(1): 20 - 24.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
Developed in Collaboration With the European Heart, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al.
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death--Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death)
J. Am. Coll. Cardiol., September 5, 2006; 48(5): 1064 - 1108.
[Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
Developed in Collaboration With the European Heart, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al.
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death)
J. Am. Coll. Cardiol., September 5, 2006; 48(5): e247 - e346.
[Full Text] [PDF]

Home page
 Eur Heart JHome page
D. P. Zipes, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al.
ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death--executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society.
Eur. Heart J., September 1, 2006; 27(17): 2099 - 2140.
[Full Text] [PDF]

Home page
 EuropaceHome page
Writing Committee Members, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al.
ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
Europace, September 1, 2006; 8(9): 746 - 837.
[Full Text] [PDF]

Home page
 CirculationHome page
N. Sadoul, R. Mletzko, F. Anselme, R. Bowes, W. Schols, C. Kouakam, G. Casteigneau, R. Luise, N. Iscolo, E. Aliot, et al.
Incidence and Clinical Relevance of Slow Ventricular Tachycardia in Implantable Cardioverter-Defibrillator Recipients: An International Multicenter Prospective Study
Circulation, August 16, 2005; 112(7): 946 - 953.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
M. R. Flynn, C. Barrett, F. G. Cosio, A. K. Gitt, L. Wallentin, P. Kearney, M. Lonergan, E. Shelley, and M. L. Simoons
The Cardiology Audit and Registration Data Standards (CARDS), European data standards for clinical cardiology practice
Eur. Heart J., February 1, 2005; 26(3): 308 - 313.
[Abstract] [Full Text] [PDF]

Home page
 EuropaceHome page
B. Sterk, A.P. van Alem, R. Tukkie, T.A. Simmers, and R.W. Koster
ICD-implantation guidelines versus clinical practice: a prospective study of out-of-hospital cardiac arrest survivors
Europace, January 1, 2004; 6(3): 179 - 183.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
J. P. DiMarco
Implantable Cardioverter-Defibrillators
N. Engl. J. Med., November 6, 2003; 349(19): 1836 - 1847.
[Full Text] [PDF]

Home page
 BMJHome page
J. M McComb and A J. Camm
Primary prevention of sudden cardiac death using implantable cardioverter defibrillators
BMJ, November 9, 2002; 325(7372): 1050 - 1051.
[Full Text] [PDF]

Home page
 Eur Heart JHome page
P. Della Bella and N. Trevisi
Catheter ablation: is it good for all postinfarction ventricular tachycardias?
Eur. Heart J., November 1, 2002; 23(21): 1645 - 1647.
[Full Text] [PDF]

Home page
 Eur Heart JHome page
M.J.P. Raatikainen and H.V. Huikuri
Management of atrial fibrillation in patients with implantable cardioverter defibrillator. Do all need a dual chamber device?
Eur. Heart J., September 2, 2002; 23(18): 1412 - 1414.
[Full Text] [PDF]

Home page
 Eur Heart J SupplHome page
C Stellbrink, A.-M Sinha, B Diem, A Auricchio, S Boccanelli, J Brugada, H Klein, J Morgan, L Padeletti, E Aliot, et al.
Implantable card ioverter-defibrillators with or without cardiac resynchronization therapy -- multiple therapy in a single device: a review with special reference to the PACIVIAN study
Eur. Heart J. Suppl., April 1, 2002; 4(suppl_D): D88 - D94.
[Abstract] [PDF]

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (32)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Hauer, R.N.W.
Right arrow Articles by Vardas, P.E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hauer, R.N.W.
Right arrow Articles by Vardas, P.E.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?